GeneVentiv Therapeutics, Inc.
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$4.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GeneVentiv Therapeutics, Inc. is a drug discovery company that develops gene therapies designed to treat rare genetic disorders. The company's treatments address hemophilia and Pompe disease, aiming to provide long-lasting and effective solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneVentiv Therapeutics, Inc. Comparables
Compare GeneVentiv Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASC Therapeutics | 77% | |
| Roche Holding | 71% | |
| Pfizer | 69% |
GeneVentiv Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Seed | Sep 1, 2022 | ||||
| Debt | Jun 8, 2022 | ||||
| Grant | Mar 16, 2022 |
GeneVentiv Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM.
- Mar 3, 2026
Monthly visitors increased 126% MoM.
GeneVentiv Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneVentiv Therapeutics, Inc.'s valuation, stock price, and market status.
Is GeneVentiv Therapeutics, Inc. a public or private company?
GeneVentiv Therapeutics, Inc. is a private company.
What is the current stock price of GeneVentiv Therapeutics, Inc.?
GeneVentiv Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is GeneVentiv Therapeutics, Inc. worth (valuation)?
Valuation information for GeneVentiv Therapeutics, Inc. is not publicly available.
Can I buy GeneVentiv Therapeutics, Inc. stock?
GeneVentiv Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneVentiv Therapeutics, Inc.'s last funding round?
Funding round information for GeneVentiv Therapeutics, Inc. is not publicly available.
Who are the main investors in GeneVentiv Therapeutics, Inc.?
Investor information for GeneVentiv Therapeutics, Inc. is not publicly disclosed.
Will GeneVentiv Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for GeneVentiv Therapeutics, Inc..
How can I track GeneVentiv Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneVentiv Therapeutics, Inc.'s secondary market activity and sign up for updates.